肺耐药蛋白是一种110kd的蛋白。
随着对非P -糖蛋白介导MDR机制研究的不断深入,肺耐药相关蛋白(LRP)被证实在MDR中发挥着重要作用,有望成为一种新的治疗靶点。
A kind of multidrug resistance, lung resistance-related protein (LRP), were demonstrated to play an important role in MDR, which might be a new therapeutic target.
应用推荐